| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.32 | 0.1 |